Lanean...
Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics
PURPOSE: In recent years, considerable progress has been made in the use of gallium-68 labeled receptor-specific peptides for imaging oncologic diseases. The objective was to examine the stability and pharmacokinetics of [(68)Ga]NODAGA and DOTA-peptide conjugate targeting VPAC [combined for vasoacti...
Gorde:
| Argitaratua izan da: | Mol Imaging Biol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487500/ https://ncbi.nlm.nih.gov/pubmed/29802552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-018-1207-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|